138 related articles for article (PubMed ID: 34136076)
1. Feasibility of allogeneic mesenchymal stem cells in pediatric hypoxic-ischemic encephalopathy: Phase I study.
Kabatas S; Civelek E; Savrunlu EC; Kaplan N; Boyalı O; Diren F; Can H; Genç A; Akkoç T; Karaöz E
World J Stem Cells; 2021 May; 13(5):470-484. PubMed ID: 34136076
[TBL] [Abstract][Full Text] [Related]
2. Phase I study on the safety and preliminary efficacy of allogeneic mesenchymal stem cells in hypoxic-ischemic encephalopathy.
Kabataş S; Civelek E; Kaplan N; Savrunlu EC; Sezen GB; Chasan M; Can H; Genç A; Akyuva Y; Boyalı O; Diren F; Karaoz E
World J Exp Med; 2021 Mar; 11(2):17-29. PubMed ID: 33821203
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficiency of Wharton's Jelly-derived mesenchymal stem cell administration in patients with traumatic brain injury: First results of a phase I study.
Kabatas S; Civelek E; Boyalı O; Sezen GB; Ozdemir O; Bahar-Ozdemir Y; Kaplan N; Savrunlu EC; Karaöz E
World J Stem Cells; 2024 Jun; 16(6):641-655. PubMed ID: 38948099
[TBL] [Abstract][Full Text] [Related]
4. Wharton's Jelly-Derived Mesenchymal Stem Cell Transplantation in a Patient with Hypoxic-Ischemic Encephalopathy: A Pilot Study.
Kabataş S; Civelek E; İnci Ç; Yalçınkaya EY; Günel G; Kır G; Albayrak E; Öztürk E; Adaş G; Karaöz E
Cell Transplant; 2018 Oct; 27(10):1425-1433. PubMed ID: 30203688
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic mesenchymal stem cells may be a viable treatment modality in cerebral palsy.
Boyalı O; Kabatas S; Civelek E; Ozdemir O; Bahar-Ozdemir Y; Kaplan N; Savrunlu EC; Karaöz E
World J Clin Cases; 2024 Mar; 12(9):1585-1596. PubMed ID: 38576742
[TBL] [Abstract][Full Text] [Related]
6. Wharton's jelly-derived mesenchymal stem cells attenuate sepsis-induced organ injury partially via cholinergic anti-inflammatory pathway activation.
Capcha JMC; Rodrigues CE; Moreira RS; Silveira MD; Dourado P; Dos Santos F; Irigoyen MC; Jensen L; Garnica MR; Noronha IL; Andrade L; Gomes SA
Am J Physiol Regul Integr Comp Physiol; 2020 Jan; 318(1):R135-R147. PubMed ID: 31596111
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
[TBL] [Abstract][Full Text] [Related]
8. hUC-MSCs Exert a Neuroprotective Effect via Anti-apoptotic Mechanisms in a Neonatal HIE Rat Model.
Xu J; Feng Z; Wang X; Xiong Y; Wang L; Ye L; Zhang H
Cell Transplant; 2019 Dec; 28(12):1552-1559. PubMed ID: 31512502
[TBL] [Abstract][Full Text] [Related]
9. Wharton's jelly-derived mesenchymal stem cells in the treatment of four patients with alopecia areata.
Czarnecka A; Odziomek A; Murzyn M; Dubis J; Bagłaj-Oleszczuk M; Hryncewicz-Gwóźdź A
Adv Clin Exp Med; 2021 Feb; 30(2):211-218. PubMed ID: 33636057
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effect of human umbilical cord mesenchymal stem cells on neonatal rat hypoxic-ischemic encephalopathy.
Zhang X; Zhang Q; Li W; Nie D; Chen W; Xu C; Yi X; Shi J; Tian M; Qin J; Jin G; Tu W
J Neurosci Res; 2014 Jan; 92(1):35-45. PubMed ID: 24265136
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effects of human umbilical cord mesenchymal stem cells transplantation on hypoxic ischemic encephalopathy.
Xie B; Gu P; Wang W; Dong C; Zhang L; Zhang J; Liu H; Qiu F; Han R; Zhang Z; Yan B
Am J Transl Res; 2016; 8(7):3241-50. PubMed ID: 27508046
[TBL] [Abstract][Full Text] [Related]
12. Magnetic targeted delivery of the SPIONs-labeled mesenchymal stem cells derived from human Wharton's jelly in Alzheimer's rat models.
Hour FQ; Moghadam AJ; Shakeri-Zadeh A; Bakhtiyari M; Shabani R; Mehdizadeh M
J Control Release; 2020 May; 321():430-441. PubMed ID: 32097673
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid-pretreated Wharton's jelly mesenchymal stem cells in combination with triiodothyronine improve expression of neurotrophic factors in the subventricular zone of the rat ischemic brain injury.
Sabbaghziarani F; Mortezaee K; Akbari M; Kashani IR; Soleimani M; Moini A; Ataeinejad N; Zendedel A; Hassanzadeh G
Metab Brain Dis; 2017 Feb; 32(1):185-193. PubMed ID: 27549229
[TBL] [Abstract][Full Text] [Related]
14. Pressure Stimuli Improve the Proliferation of Wharton's Jelly-Derived Mesenchymal Stem Cells under Hypoxic Culture Conditions.
Park SE; Kim H; Kwon S; Choi SJ; Oh SY; Ryu GH; Jeon HB; Chang JW
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993025
[TBL] [Abstract][Full Text] [Related]
15. Comparison between the effect of human Wharton's jelly-derived mesenchymal stem cells and levetiracetam on brain infarcts in rats.
Abd El Motteleb DM; Hussein S; Hasan MM; Mosaad H
J Cell Biochem; 2018 Dec; 119(12):9790-9800. PubMed ID: 30171723
[TBL] [Abstract][Full Text] [Related]
16. Cell-based treatment for perinatal hypoxic-ischemic encephalopathy.
Park YJ; Borlongan CV; Dezawa M
Brain Circ; 2021; 7(1):13-17. PubMed ID: 34084971
[TBL] [Abstract][Full Text] [Related]
17. Improving stemness and functional features of mesenchymal stem cells from Wharton's jelly of a human umbilical cord by mimicking the native, low oxygen stem cell niche.
Obradovic H; Krstic J; Trivanovic D; Mojsilovic S; Okic I; Kukolj T; Ilic V; Jaukovic A; Terzic M; Bugarski D
Placenta; 2019 Jul; 82():25-34. PubMed ID: 31174623
[TBL] [Abstract][Full Text] [Related]
18. An Injectable Hyaluronan-Methylcellulose (HAMC) Hydrogel Combined with Wharton's Jelly-Derived Mesenchymal Stromal Cells (WJ-MSCs) Promotes Degenerative Disc Repair.
Choi UY; Joshi HP; Payne S; Kim KT; Kyung JW; Choi H; Cooke MJ; Kwon SY; Roh EJ; Sohn S; Shoichet MS; Han I
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036383
[TBL] [Abstract][Full Text] [Related]
19. Intrathecal Injection in A Rat Model: A Potential Route to Deliver Human Wharton's Jelly-Derived Mesenchymal Stem Cells into the Brain.
Kim H; Na DL; Lee NK; Kim AR; Lee S; Jang H
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32070050
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Dosing of Intrathecal Baclofen in the Treatment of Spasticity After Acquired Brain Injury.
Maneyapanda MB; McCormick ZL; Marciniak C; Reger C
PM R; 2017 Jun; 9(6):556-562. PubMed ID: 28082177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
